Decreasing Over Screening and Treatment of Cervical Precancers in Young Women

Summary

The goal of this study is to prevent over screening and over treatment of young women for cervical precancers, which can result in psychological distress and has been associated with future risk of premature deliveries. Current national guidelines recommend that routine screening be performed at less-frequent intervals and that excisional cervical therapies are discouraged in young women. The objectives of this study are to examine physician- and patient-based interventions designed to decrease over screening and over treatment by increasing adherence to US guidelines for women under 30 years.

Conditions

• Cervical Cancer

Interventions

OTHER

Provider Mobile Application (ProvAPP)

Mobile phone application to maneuver clinicians through the cervical cancer screening and treatment guidelines based on patient age and condition.

OTHER

ProvAPP + Patient Educational Tool (Tab)

Patient Educational Tool (Tab): A patient educational tool (mobile tablet) will educate women on cervical cancer screening and treatment. Patients' self-assessment using a tablet at the time of clinic check-in will help them to understand current guidelines and their choices for treatment if they have abnormal cytology. It will allow them to assess the risks and benefits of screening intervals and of treatment choices. ProvAPP: Mobile phone application to maneuver clinicians through the cervical cancer screening and treatment guidelines based on patient age and condition.

Sponsors & Collaborators

• Patient-Centered Outcomes Research Institute

  collaborator OTHER

• Latinas Contra Cancer

  collaborator UNKNOWN

• National Cervical Cancer Coalition

  collaborator UNKNOWN

• California Department of Health Services

  collaborator OTHER

• American College of Obstetricians and Gynecologists

  collaborator OTHER

• American Society for Colposcopy and Cervical Pathology

  collaborator OTHER

• University of California, San Francisco

  lead OTHER

Principal Investigators

• Anna-Barbara Moscicki, MD · University of California, San Francisco

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

21 Years

Max Age

29 Years

Sex

FEMALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2014-07-24

Primary Completion

2018-04-30

Completion

2019-08-30

Countries

• United States

Study Locations